Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
    • GP-001 Documents and records control
    • GP-002 Quality planning
    • GP-003 Audits
    • GP-004 Vigilance system
    • GP-005 HR and training
    • GP-007 Post-market surveillance
    • GP-009 Sales
    • GP-010 Suppliers
    • GP-012 Design, Redesign and Development
      • R-012-004 Software version release for Brazil
      • R-012-010 Device backup verification_2023_001
      • R-012-012 Customers product version control
      • R-012-017 Integration test review
    • GP-018 Infrastructure and facilities
    • GP-019 Software validation
    • GP-023 Change control management
    • GP-050 Data Protection
    • GP-051 Security violations
    • GP-052 Data Privacy Impact Assessment (DPIA)
    • GP-200 Remote Data Acquisition in Clinical Investigations
  • TF_Legit.Health_Plus
  • Licenses and accreditations
  • External documentation
  • Records
  • GP-012 Design, Redesign and Development

GP-012 Design, Redesign and Development

📄️ R-012-004 Software version release for Brazil

This document is a draft version. This software version will be officially approved and released once the ANVISA approval is obtained.

📄️ R-012-010 Device backup verification_2023_001

Evidence

📄️ R-012-012 Customers product version control

Customers product version control

📄️ R-012-017 Integration test review

Description of integration test plan

Previous
R-010-001 Suppliers evaluation
Next
R-012-004 Software version release for Brazil
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI LABS GROUP S.L.)